Abstract

To evaluate birth outcomes in women with hypertensive disorders of pregnancy (HDP) and gestational diabetes mellitus (GDM), we used insurance data of Taiwan to evaluate 11 adverse neonatal outcomes of infants born to women with HDP (N = 7775) and with both HDP and GDM (HDP/GDM) (N = 1946), comparing to women with neither disorder (N = 19,442), matched by age. The impacts of preeclampsia/eclampsia were also evaluated. Results showed that Caesarean section delivery was near 1.7-fold greater in the HDP/GDM and HDP groups than in comparisons. The preterm delivery rates were more than threefold greater in HDP/GDM group and HDP group than in comparisons with adjusted odds ratios (aORs) of 4.84 (95% confidence interval (CI) 4.34–5.40) and 3.92 (95% CI 3.65–4.21), respectively, followed by jaundice (aORs 2.95 (95% CI 2.63–3.33) and 1.90 (95% CI 1.76–2.06)), and small gestation age (SGA) (aORs 6.57 (95% CI 5.56–7.75) and 5.81 (95% CI 5.15–6.55)). Incidence rates of birth trauma, patent ductus arteriosus, atrial septal defect, respiratory distress syndrome, and neonatal hypoglycemia were also higher in the HDP/GDM and HDP groups than in the comparison group. Most adverse outcomes increased further in women with preeclampsia or eclampsia. In conclusion, women with HDP are at elevated risks of adverse neonatal outcomes. Risks of most adverse outcomes increase further for women with both HDP and GDM. Preeclampsia or eclampsia may also contribute to these outcomes to higher risk levels. Every pregnant woman with these conditions deserves specialized prenatal care.

Details

Title
Population-based study on birth outcomes among women with hypertensive disorders of pregnancy and gestational diabetes mellitus
Author
Ya-Wen, Lin 1 ; Ming-Hung, Lin 2 ; Lee-Wen, Pai 3 ; Jen-Wei, Fang 4 ; Mou Chih-Hsin 5 ; Fung-Chang, Sung 6 ; Ya-Ling, Tzeng 7 

 China Medical University, School of Nursing and Graduate Institute of Nursing, Taichung, Taiwan (GRID:grid.254145.3) (ISNI:0000 0001 0083 6092); China Medical University, Department of Public Health, Taichung, Taiwan (GRID:grid.254145.3) (ISNI:0000 0001 0083 6092) 
 Tajen University, Department of Pharmacy and Master Program, Pingtung, Taiwan (GRID:grid.412902.c) (ISNI:0000 0004 0639 0943) 
 Central Taiwan University of Science and Technology, Department of Nursing, Taichung, Taiwan (GRID:grid.411043.3) (ISNI:0000 0004 0639 2818) 
 China Medical University Hospital, Department of Obstetrics and Gynecology, Taichung, Taiwan (GRID:grid.411508.9) (ISNI:0000 0004 0572 9415) 
 China Medical University Hospital, Management Office for Health Data, Taichung, Taiwan (GRID:grid.411508.9) (ISNI:0000 0004 0572 9415) 
 China Medical University Hospital, Management Office for Health Data, Taichung, Taiwan (GRID:grid.411508.9) (ISNI:0000 0004 0572 9415); China Medical University, Department of Health Services Administration, Taichung, Taiwan (GRID:grid.254145.3) (ISNI:0000 0001 0083 6092); Asia University, Department of Food Nutrition and Health Biotechnology, Taichung, Taiwan (GRID:grid.252470.6) (ISNI:0000 0000 9263 9645) 
 China Medical University, School of Nursing and Graduate Institute of Nursing, Taichung, Taiwan (GRID:grid.254145.3) (ISNI:0000 0001 0083 6092); China Medical University Hospital, Department of Nursing, Taichung, Taiwan (GRID:grid.411508.9) (ISNI:0000 0004 0572 9415) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2566145645
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.